IN8bio, Inc. - Common Stock — Cash Flow (NASDAQ:INAB)

Financials

Cash from operating activities -13.51 M-24.12 M-23.34 M-24.15 M-12.71 M -14.54 M Cash from investing activities -309 K-3.71 M-600 K-187 K0 -9 000 Cash from financing activities 32.95 M8.99 M27.04 M14.18 M28.64 M 24.55 M Free cash flow -13.51 M-24.12 M-23.34 M-24.15 M-12.71 M -14.54 M

INAB

Financials

News

H.C. Wainwright reiterates IN8bio stock rating on financing strength

IN8bio appoints Kate Rochlin as president while retaining COO role

IN8bio promotes Kate Rochlin to president and chief operating officer

IN8bio secures up to $40.2 million in private placement for cancer therapy

Mizuho lowers IN8bio stock price target on financing concerns

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

INB-200 shows promise in glioblastoma trial

IN8bio reports promising lupus treatment data